AGP Picks
View all

America Latina Times
Provided by AGP

America Latina Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on America Latina Times.

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Press releases published on June 8, 2026

Tango Therapeutics Announces Proposed $500 Million Public Offering
Jun. 8, 2026

Tango Therapeutics Announces Proposed $500 Million Public Offering

Indeterminate GlobeNewswire
AML Consulting Launches Startup Video Press Release Builder for Multimedia Content Creation
Jun. 8, 2026

AML Consulting Launches Startup Video Press Release Builder for Multimedia Content Creation

Indeterminate EIN Presswire
Oculis to Present at the 47th Annual Goldman Sachs Global Healthcare Conference
Jun. 8, 2026

Oculis to Present at the 47th Annual Goldman Sachs Global Healthcare Conference

Indeterminate GlobeNewswire
DXRACER se une a la celebración del décimo aniversario de Dead by Daylight con sillas gaming exclusivas de serie CRAFT
Jun. 8, 2026

DXRACER se une a la celebración del décimo aniversario de Dead by Daylight con sillas gaming exclusivas de serie CRAFT

Indeterminate EIN Presswire
XS.com Conclui a Turnê LATAM com Sucesso em Evento Privado para Clientes e Parceiros
Jun. 8, 2026

XS.com Conclui a Turnê LATAM com Sucesso em Evento Privado para Clientes e Parceiros

Indeterminate EIN Presswire
XS.com Concluye una Exitosa Gira LATAM con un Evento Privado para Clientes y Socios
Jun. 8, 2026

XS.com Concluye una Exitosa Gira LATAM con un Evento Privado para Clientes y Socios

Indeterminate EIN Presswire
High-Grade Antimony Assays from Trenching on the South Zone on the Bald Hill Property Under Option from Globex
Jun. 8, 2026

High-Grade Antimony Assays from Trenching on the South Zone on the Bald Hill Property Under Option from Globex

Indeterminate GlobeNewswire
Cosmos Health Completes Acquisition of Strategic Intellectual Property and Expands Nanotechnology Investment Initiatives
Jun. 8, 2026

Cosmos Health Completes Acquisition of Strategic Intellectual Property and Expands Nanotechnology Investment Initiatives

Indeterminate GlobeNewswire
Anortech Enters Carbon Capture Research Collaboration with the National Research Council of Canada
Jun. 8, 2026

Anortech Enters Carbon Capture Research Collaboration with the National Research Council of Canada

Indeterminate GlobeNewswire
ADARx Pharmaceuticals to Present Onvuzosiran (ADX-324) Phase 1/2 Clinical Data Supporting the Ongoing Phase 3 STOP-HAE Clinical Trial at the 2026 Annual EAACI Congress
Jun. 8, 2026

ADARx Pharmaceuticals to Present Onvuzosiran (ADX-324) Phase 1/2 Clinical Data Supporting the Ongoing Phase 3 STOP-HAE Clinical Trial at the 2026 Annual EAACI Congress

Indeterminate GlobeNewswire
Inter Opens U.S. Branch in Miami
Jun. 8, 2026

Inter Opens U.S. Branch in Miami

Indeterminate GlobeNewswire
QED invertirá en el negocio de crédito de FEMSA
Jun. 8, 2026

QED invertirá en el negocio de crédito de FEMSA

Indeterminate GlobeNewswire
QED to invest in FEMSA’s lending venture
Jun. 8, 2026

QED to invest in FEMSA’s lending venture

Indeterminate GlobeNewswire
Alkeus Pharmaceuticals Announces First Patient Dosed in Pivotal Global Phase 3 NORTHSTAR Study of Oral Gildeuretinol in Stargardt Disease
Jun. 8, 2026

Alkeus Pharmaceuticals Announces First Patient Dosed in Pivotal Global Phase 3 NORTHSTAR Study of Oral Gildeuretinol in Stargardt Disease

Indeterminate GlobeNewswire
Ambros Therapeutics Announces First Patient Dosed in Pivotal CRPS-RISE Phase 3 Clinical Trial of Neridronate in Patients with Complex Regional Pain Syndrome Type 1
Jun. 8, 2026

Ambros Therapeutics Announces First Patient Dosed in Pivotal CRPS-RISE Phase 3 Clinical Trial of Neridronate in Patients with Complex Regional Pain Syndrome Type 1

Indeterminate GlobeNewswire
AIM ImmunoTech Reports Positive Mid-Year Interim Clinical Progress from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer
Jun. 8, 2026

AIM ImmunoTech Reports Positive Mid-Year Interim Clinical Progress from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer

Indeterminate GlobeNewswire
Consolidated Water Appoints Water Industry Veteran Sachin Chawla as Senior Vice President, Strategy and Growth
Jun. 8, 2026

Consolidated Water Appoints Water Industry Veteran Sachin Chawla as Senior Vice President, Strategy and Growth

Indeterminate GlobeNewswire
Sparrow Pharmaceuticals Announces Phase 2a Data Showing Cardiometabolic Benefits of Clofutriben in Adults with Type 2 Diabetes
Jun. 8, 2026

Sparrow Pharmaceuticals Announces Phase 2a Data Showing Cardiometabolic Benefits of Clofutriben in Adults with Type 2 Diabetes

Indeterminate GlobeNewswire
U.S. Court of Appeals for the Federal Circuit Affirms Victory for Cormedix Therapeutics in Minocin® Patent Litigation
Jun. 8, 2026

U.S. Court of Appeals for the Federal Circuit Affirms Victory for Cormedix Therapeutics in Minocin® Patent Litigation

Indeterminate GlobeNewswire
JET.AI ANNOUNCES LEADING INDEPENDENT PROXY ADVISORY FIRM ISS RECOMMENDS STOCKHOLDERS VOTE “FOR” THE PROPOSED MERGER
Jun. 8, 2026

JET.AI ANNOUNCES LEADING INDEPENDENT PROXY ADVISORY FIRM ISS RECOMMENDS STOCKHOLDERS VOTE “FOR” THE PROPOSED MERGER

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

America Latina Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.